Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2008 by Rabin Medical Center.
Recruitment status was:  Recruiting
Academic College of Tel Aviv-Jaffa
Israel Cancer Association
Information provided by:
Rabin Medical Center Identifier:
First received: July 30, 2008
Last updated: February 15, 2009
Last verified: July 2008
The purpose of this study is to asses the impact of a tailored preoperative psychological intervention on women with gynecological malignancies on psychological, physiological and immunological parameters

Condition Intervention Phase
Cancer of Cervix
Ovarian Cancer
Cancer of Endometrium
Behavioral: Cognitive intervention
Other: Control group
Other: psycho-physiological intervention
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Assessment of the Impact of Preoperative Stress Reduction on Psychological, Physiological and Immunological Parameters in Women With Gynecological Malignancies - Prospective Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • psychological, physiological, immunological parameters [ Time Frame: A week before surgery, the day befor surgery, day of hospital discharge, one month after surgery ]

Estimated Enrollment: 60
Study Start Date: August 2008
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Women in this arm will not receive a psychological intervention but rather will have a conversation with a nurse for one hour (attention control).
Other: Control group
A one hour conversation with a nurse
Experimental: 2
Cognitive intervention: Women in this arm will receive a cognitive psychological intervention(cognitive technique:self-talk)
Behavioral: Cognitive intervention
The intervention will last one hour and will include cognitive technique (self-talk). The technique will be demonstrated to the woman, practiced with her, and taped so as to encourage further practice at home.
Other Name: Tailored cognitive intervention
Experimental: 3
Psycho-physiological intervention: Women in this arm will receive a psycho-physiological intervention (relaxation and guided imagery)
Other: psycho-physiological intervention
The intervention will last an hour and will include a psycho-physiological intervention (relaxation and guided imagery). The technique will be demonstrated to the woman, practiced with her, and taped so as to assure further practice at home
Other Name: tailored psycho-physiological intervention

Detailed Description:

Surgery is considered one of the most stressful events in human life. Research indicates that patients show high levels of stress from at least six days before surgery and up to a week post the operation. Stress levels return to normalcy only after several weeks. Research shows that psychological interventions given to women suffering from cancer can improve their coping abilities and overall function, decreases stress levels, enhances adherence to treatments,and increases quality of life and even life expectancy.

Women enrolled in this study will be divided into two groups: an experimental group and a control group. Both groups will receive standard care. The control group will interact with a nurse for one hour. The experimental group will receive one of two forms of psychological intervention: either a cognitive intervention, or a psychophysiological intervention (tailored to each woman).

Measurements and Instruments include: 1) Self-report questionnaires, such as:Profile of Mood States (POMS-SF),Coping Inventory (COPE), Life Orientation Test Revised (LOT- R),Stress Level Report, 2) Demographics, 3) Global assessment by the head nurse. 4)Physiological and behavioral measures, such as: vital signs and use of medicine. 5)Hormonal and immunological measures: levels of cortisol in saliva and plasma, levels of catecholamines in plasma, salivary levels of IgA1, and peripheral blood NK cells and lymphocyte phenotyping.6)levels of cytokines including IL-1,2,4,6,10,12, TNF-alpha, Interferon-gamma.

Time intervals for the collection of blood and saliva and the administration of the questionnaires:

During the first week after being given the diagnosis and prior to the intervention:Blood & saliva, Stress Level Report, POMS-SF, COPE, LOT-R

A day prior to surgery:Blood & saliva, Stress Level Report

On discharge from hospital:Blood & saliva, Stress Level Report

30 days after surgery:Stress Level Report,POMS-SF,COPE,LOT-R.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Woman with ovarian, cervical or endometrial cancer/tumor
  • Women who speak Hebrew
  • Women who sign the consent form

Exclusion Criteria:

  • Women who have received neoadjuvant treatment
  • Women suffering from any form of depression, anxiety or schizophrenia
  • Women suffering from autoimmune or infectious diseases
  • Women taking medications which have immunological effects (steroids ,beta-blockers)
  • Women suffering from dementia or concentration problems
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00726635

Contact: Opher Caspi, MD PhD 972-39377995

Rabin Medical center Recruiting
Petah Tikva, Israel, 49100
Contact: Opher Caspi, MD PhD    972-3937795   
Contact: Mira Livingstone, B.A    972-542562083   
Principal Investigator: Opher Caspi, MD PhD         
Sponsors and Collaborators
Rabin Medical Center
Academic College of Tel Aviv-Jaffa
Israel Cancer Association
Principal Investigator: Opher Caspi, MD PhD Director, Integrative Medicine - Rabin Medical Center
  More Information

Responsible Party: Opher Caspi, MD PhD, Rabin Medical Center Identifier: NCT00726635     History of Changes
Other Study ID Numbers: 0014-08-RMC
Study First Received: July 30, 2008
Last Updated: February 15, 2009

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Endometrial Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female processed this record on May 22, 2017